NCT03789448View on ClinicalTrials.gov

Early Access to ART for All in Swaziland: Effects on Economic Outcomes

NACompletedINTERVENTIONAL
Enrollment

3,019

Participants

Timeline

Start Date

September 1, 2014

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
HIV/AIDS
Interventions
OTHER

Early Access to ART for All

All HIV-positive individuals will be initiated on Swaziland's recommended first-line ART regimen, unless contraindicated when recommended alternate regimens will be used per national guidelines

All Listed Sponsors
collaborator

Clinton Health Access Initiative Inc.

OTHER

lead

Till Bärnighausen

OTHER

NCT03789448 - Early Access to ART for All in Swaziland: Effects on Economic Outcomes | Biotech Hunter | Biotech Hunter